Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.595 USD | +19.92% | +14.03% | +175.65% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+175.65% | 342M | |
+21.92% | 47.9B | |
+46.56% | 41.42B | |
-2.49% | 40.7B | |
-6.20% | 28.92B | |
+10.86% | 25.55B | |
-21.30% | 19.27B | |
-1.80% | 12.15B | |
+30.56% | 12.14B | |
-0.49% | 11.99B |
- Stock Market
- Equities
- OCGN Stock
- News Ocugen, Inc.
- Ocugen Doses First Patient in Phase 1/2 Trial of Gene Therapy to Treat Retinal Degeneration